Evidence map›Paper›PMID 19487691›Full record

ArticleThe Journal of biological chemistry2009

Chemical genetic profiling and characterization of small-molecule compounds that affect the biosynthesis of unsaturated fatty acids in Candida albicans.

Deming Xu, Susan Sillaots, John Davison, Wenqi Hu, Bo Jiang, Sarah Kauffman, Nick Martel, Pam Ocampo, Chanseok Oh, Steve Trosok and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Journal of fungi (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antibody screening reveals antigenic proteins involved inFrontiers in cellular and infection microbiology · 2023
    Article
  13. Review
  14. Article
  15. Review
  16. Science translational medicine · 2021
    Article
  17. Campafungins: Inhibitors ofJournal of natural products · 2020
    Article
  18. New Insights inFrontiers in cellular and infection microbiology · 2020
    Review
  19. Chemogenomic Profiling of the Fungal Pathogen Candida albicans.Antimicrobial agents and chemotherapy · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Deming XuCenter of Fungal Genetics, Merck-Frosst Canada Ltd., Montreal, Quebec H9H 3L1, Canada. xu_deming@hotmail.com
Susan Sillaots
John Davison
Wenqi Hu
Bo Jiang
Sarah Kauffman
Nick Martel
Pam Ocampo
Chanseok Oh
Steve Trosok
Karynn Veillette
Hao Wang
Minghui Yang
Li Zhang
Jeffrey Becker
Charles E Martin
Terry Roemer
Merck Canada Inc. (Canada) · CARutgers, The State University of New Jersey · USUniversity of Tennessee at Knoxville · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The balance between saturated and unsaturated fatty acids plays a crucial role in determining the membrane fluidity. In the diploid fungal pathogen Candida albicans, the gene for fatty acid Delta9 desaturase, OLE1, is essential for viability. Using a reverse genetic approach, termed the fitness test, we identified a group of structurally related synthetic compounds that induce specific hypersensitivity of the OLE1(+/-) strain. Genetic repression of OLE1 and chemical inhibition by two selected compounds, ECC145 and ECC188, resulted in a marked decrease in the total unsaturated fatty acids and impaired hyphal development. The resulting auxotroph of both was suppressed by the exogenous monounsaturated fatty acids (16:1Delta9 and 18:1Delta9). These correlations suggest that both compounds affect the level of unsaturated fatty acids, likely by impairing Ole1p directly or indirectly. However, the residual levels of monounsaturated fatty acids (MUFAs) resulted from chemical inhibition were significantly higher than OLE1 repression, indicating even partial inhibition of MUFAs is sufficient to stop cellular proliferation. Although the essentiality of OLE1 was suppressed by MUFAs in vitro, we demonstrated that it was required for virulence in a murine model of systemic candidiasis even when the animals were supplemented with a high fat diet. Thus, the fungal fatty acid desaturase is an attractive antifungal drug target. Taking advantage of the inhibitors and the relevant conditional shut-off strains, we validated several chemical genetic interactions observed in the fitness test profiles that reveal novel genetic interactions between OLE1/unsaturated fatty acids and other cellular processes.

Indexed as

Gene Expression ProfilingAnimalsAntifungal AgentsCandida albicansCandidiasisCeruleninCluster AnalysisFatty Acid DesaturasesFatty Acids, UnsaturatedFungal ProteinsGene Expression Regulation, FungalHyphaeMaleMiceMice, Inbred ICRMolecular StructureAntifungal AgentsCerulenindelta-9 fatty acid desaturaseECC 145ECC 188Fatty Acid DesaturasesFatty Acids, UnsaturatedFungal ProteinsStearoyl-CoA DesaturaseThiazolesTriazoles

Identifiers

PMID19487691
PMCPMC2740599
OpenAlexW2002979500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.